InvestorsHub Logo
Followers 12
Posts 882
Boards Moderated 0
Alias Born 03/26/2011

Re: TheHungryHippo post# 11138

Friday, 12/14/2018 3:09:42 PM

Friday, December 14, 2018 3:09:42 PM

Post# of 27660
The Question is:
1. Why did Mymetics give Anergis a time LIMITED option to enter an exclusive licensing agreement?

quote:
Anergis has time limited exclusive option to license Mymetics' virosome technology in the field of allergies

https://finance.yahoo.com/news/mymetics-virosomes-successful-allergy-proof-060000598.html


2. Why did Anergis agree to such term?

quote:
Should Anergis and Mymetics execute a License and Collaboration Agreement (LCA), Anergis would make an upfront payment to Mymetics in an amount that increases as the date of executing the LCA is delayed, milestone payments based on certain regulatory clearances and royalties for net sales.

https://www.sec.gov/Archives/edgar/data/927761/000165495418004222/mymx_8k.htm


~ Is it because there are others in line?
~ Is it because Anergis wanted to seal the deal before Mymetics gets bought?
~ Knowing the background of Anergis' CEO and BOD, will they consider a licensing deal? or M&A?
~ What's SANOFI's interest in Allergy Immunotherapies?

Just thinking out loud (imho)


regards,





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MYMX News